clinical study on sooli kanam (Bronchial asthma) with evaluation of siddha trial drug - Kannaiku atthi nei in children

Phase 2

Not yet recruiting

• Conditions: Other and unspecified asthma,

• Registration Number: CTRI/2020/10/028491
• Lead Sponsor: Government siddha medical college chennai

Brief Summary

This is an phase II open single non randomized study to evaluate the official Siddha formulaiton "Kannaiku atthi nei" internally for Bronchial asthma (sooli kanam) . The trial drug is given 2 to 5 ml twice a day for 21 days. clinical trial conducted after conducting pre-clinical toxicity study. The trial drug Kannaiku atthi nei is mentioned in kumbamuni balavagadam book. During the trial study related data will be recorded and documented. after the completion of the trial all the data will be analysed statistically.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-10-20
• Study Start: 2020-10-25

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

age 3 to 12 years cough without expulsion wheezing dyspnea rhinitis.

Exclusion Criteria

primary complex hypersensitivity pneumonitis lung abscess cystic fibrosis bronchiolitis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
clinical assesment of bronchial asthma is carried out on the basis of modified asthma scale, and comparing the clinical symptoms before and after treatment	21 days

Secondary Outcome Measures

Name	Time	Method
it is assessed by comparing the safety parameters before and after treatment	21 days

Trial Locations

Locations (1)

Aringar Anna hospital of Indian medicine; 🇮🇳 Chennai, TAMIL NADU, India

Aringar Anna hospital of Indian medicine

🇮🇳Chennai, TAMIL NADU, India

Dr P Shobanashree

Principal investigator

9942912256

dr.shobanashree301@gmail.com